Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Hapten-augmentable plaque-forming cells PFC) are cells whose secretion of antibody is specifically inibited by surface-bound auto-anti-iodotype antibody th can be displaced by hapten. This study showed that the percentage of hapten-augmentable PFC present in mice during the primary response to trinitrohenat FicolI(NP-F) increases with age.The data suggest gat there is a relative increase in the autoanti-idiotypic antibody response with age and therefore a greater down-regulation of antibody production. The effect of age on idiotype expression was also studied. Hapten-reversible inhibition of plaque formation was used as an assay for antiidiotype antibody and idiotype bearing antibody-secreting cells.Sera from aged (21-to 22onth-otd)C57BL/6 mice immunized with TNP-F significantly inhibited plaque formation, in a hapten-reversible manner, by spleen cells from 81% of TNP-F-immunized aged mice. However, these sera inhibited plaque formation by cells from only 50% of similarly immunized young adult (6-to 8-week-old) mice and 20% of immature (3-to 4-week-old) syngeneic mice. Similarly, sera from TNP-F-immunized young adult or immature mice inhibited formation of plaques by cells from immunized donors of the same age as the mice from whom the serum was obtained, but only rarely inhibited plaque formation by cells from mice of other age groups. The data thus suggest that the repertoire of TNP-specific idiotypes that are produced in response to TNP-F varies with age in syngeneic mice.We have shown that, in the presence of low concentrations of hapten, there frequently is an increase in the number of plaque-forming cells (PFC) detected (1, 2) in a Jerne PFC assay (3). These hapten-augmentable PFC represent potential antibody-producing cells whose secretion appears to have been inhibited by the binding of auto-anti-idiotype antibody to cell-surface antibody molecules. Hapten competes with antiidiotype antibody for available cell-surface antibody molecules and, in this manner, displaces bound anti-idiotype antibody and reverses its inhibitory effect on antibody secretion. We have also shown that serum anti-idiotype antibody can be assayed by its ability to cause a hapten-reversible inhibition of plaque formation (2). By using these assays, we have found that the immune response to both thymic-dependent and thymic-independent antigens is down-regulated by the production of auto-anti-idiotype antibodies (unpublished results). From these studies, we have concluded that auto-anti-idiotype antibody serves as a normal mechanism for immune regulation in a manner compatible with predictions based on Jerne's network theory (4). Several other groups have also shown that autoanti-idiotype antibodies are produced during a normal immune response (5-7).The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.6788
Hapten-augmentable plaque-forming cells PFC) are cells whose secretion of antibody is specifically inibited by surface-bound auto-anti-iodotype antibody th can be displaced by hapten. This study showed that the percentage of hapten-augmentable PFC present in mice during the primary response to trinitrohenat FicolI(NP-F) increases with age.The data suggest gat there is a relative increase in the autoanti-idiotypic antibody response with age and therefore a greater down-regulation of antibody production. The effect of age on idiotype expression was also studied. Hapten-reversible inhibition of plaque formation was used as an assay for antiidiotype antibody and idiotype bearing antibody-secreting cells.Sera from aged (21-to 22onth-otd)C57BL/6 mice immunized with TNP-F significantly inhibited plaque formation, in a hapten-reversible manner, by spleen cells from 81% of TNP-F-immunized aged mice. However, these sera inhibited plaque formation by cells from only 50% of similarly immunized young adult (6-to 8-week-old) mice and 20% of immature (3-to 4-week-old) syngeneic mice. Similarly, sera from TNP-F-immunized young adult or immature mice inhibited formation of plaques by cells from immunized donors of the same age as the mice from whom the serum was obtained, but only rarely inhibited plaque formation by cells from mice of other age groups. The data thus suggest that the repertoire of TNP-specific idiotypes that are produced in response to TNP-F varies with age in syngeneic mice.We have shown that, in the presence of low concentrations of hapten, there frequently is an increase in the number of plaque-forming cells (PFC) detected (1, 2) in a Jerne PFC assay (3). These hapten-augmentable PFC represent potential antibody-producing cells whose secretion appears to have been inhibited by the binding of auto-anti-idiotype antibody to cell-surface antibody molecules. Hapten competes with antiidiotype antibody for available cell-surface antibody molecules and, in this manner, displaces bound anti-idiotype antibody and reverses its inhibitory effect on antibody secretion. We have also shown that serum anti-idiotype antibody can be assayed by its ability to cause a hapten-reversible inhibition of plaque formation (2). By using these assays, we have found that the immune response to both thymic-dependent and thymic-independent antigens is down-regulated by the production of auto-anti-idiotype antibodies (unpublished results). From these studies, we have concluded that auto-anti-idiotype antibody serves as a normal mechanism for immune regulation in a manner compatible with predictions based on Jerne's network theory (4). Several other groups have also shown that autoanti-idiotype antibodies are produced during a normal immune response (5-7).The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.6788
We have previously shown that old mice produce more hapten-augmentable plaque-forming cells (PFC) than do young animals, suggesting a greater auto-antiidiotype antibody (auto anti-Id) component in their immune response. In the present studies this is confirmed serologically. The marked auto-anti-Id response of aged mice can be transferred to lethally irradiated young recipients with spleen but not bone marrow cells from old donors, suggesting that it is an intrinsic property of their peripheral B cell population and that the distribution of Id arising from the bone marrow of old and young mice is similar. In contrast with young mice the auto-anti-Id response of old animals is relatively T cell-independent and old donors do not show an increase in their ability to transfer an auto-anti-Id response after priming with TNP-F. These observations suggest that old mice behave as if already primed for auto-anti-Id production. Irradiated mice reconstituted with bone marrow cells from either young or old donors together with splenic T cells from old donors generate a relatively large auto-anti-Id response, whereas mice reconstituted with bone marrow from either young or old donors together with splenic T cells from young donors produce few hapten-augmentable PFC. It is suggested that differences in Id expression and auto-anti-Id production are the consequences of the interaction of Id (and anti-Id) arising from the marrow with anti-Id (and Id) present in the peripheral T cell population which serves as a repository of information about shifts in Id distribution, resulting from lifelong interactions with environmental and self-antigens.
Immunological tolerance in the mouse thymus cell population induced by the intravenous injection of deaggregated bovine gamma globulin was terminated by whole body irradiation. After irradiation, the weight of the thymus recovered biphasically, and the termination of tolerance occurred as early as in the first phase. Both Thv-I antigen expression and helper activity of the thymus cell population in irradiated mice recovered in parallel with the recovery of the thymus weight. Sensitivity of the regenerating thymus cells to the tolerogen was not different from that of the normal thymus cells. The first phase of thymus regeneration may be caused by the proliferation and differentiation of relatively radioresistant and tolerogen insensitive precursors residing in the thymus. Tolerogen and/or immunogen reactive thymus cells may originate from the precursor.Mouse thymic lymphocytes are known to originate from precursor cells in the bone marrow (11,19,27). The precursor cells proliferate and differentiate into thymic lymphocytes having unique functions and surface markers under the influence of the thymic environment (6,20,26). For investigating the characteristics of thymic lymphocyte precursors, thymus regeneration after irradiation has presented a good model for the maturation of thymic lymphocytes, since the regeneration seems to recapitulate, at least partly, the developmental process of thymic lymphocytes (5, 10,32).The tolerant state induced by deaggregated heterologous proteins persists for a long time in thymic lymphocyte and peripheral T cell populations (34). Although such long-term maintenance of tolerance may be attributable to slow turnover of T cells in the thymus and in the recirculating pool, recovery from tolerance is markedly retarded by thymectomy of the tolerant animal (8). This seems to indicate that lymphocytes formed in the thymus after the induction of tolerance are progeny of tolerogen-insensitive, or antigen-uncommitted, precursor cells.The present study was undertaken to investigate the relationship between the development and the antigen sensitivity of thymus cells. Thus, primary interest
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.